European Regulator Pulls Marketing Authorizations For Tecfidera Generics
Several Companies Affected, After Biogen Won CJEU Decision On Exclusivity
In a blow to several generics firms – albeit one telegraphed by a decision handed down nine months ago – the European Commission has ordered the removal of marketing authorizations for generic versions of Biogen’s MS brand, Tecfidera.
